BioSpace News Archive

New learning system and certification program sets international standard for professional status as a RAPID imaging practitioner. Empowers multiple members of stroke care teams to quickly become proficient

Built on a foundation of leading science and technology, USANA continues to stake its claim at the forefront of the health and wellness industry with its recent award from Global Health & Pharma magazine.

Echosens, an innovative high-technology company offering the FibroScan family of products, has funded an ongoing study conducted by the Florida Research Institute, a global leader in disease research

The global attention deficit hyperactivity disorder (ADHD) drugs market is expected to post a CAGR of close to 6% during the period 2019-2023, according to the latest market research report by Technavio.

NextGen Healthcare, Inc., a leading provider of ambulatory-only technology solutions, will release its fiscal 2019 fourth quarter and year ended March 31, 2019 operating results on Thursday, May 23, 2019 after market close, with a conference call to follow at 5:00 p.m. Eastern Time.

The PHAB Awards to be one of the largest industry-funded grant programs focused on pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

A new analysis of financial data from general acute care hospitals in California reveals that private insurers paid on average 209 percent more than what Medicare paid for similar services in 2015 and 2016.

Strata Oncology, Inc. announced that data from its Strata Trial, a nationwide observational NGS screening protocol providing no-cost tumor sequencing and clinical trial matching for 100,000 advanced cancer patients, will be presented in a poster at the upcoming 2019 American Society of Clinical Oncology Annual Meeting, taking place in Chicago, IL, from May 31-June 4, 2019.

Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into a collaboration with the Alliance for Clinical Trials in Oncology Foundation (Alliance), a US-based cancer research network sponsored by the National Cancer Institute.

RVT-1601 previously demonstrated a statistically significant and clinically meaningful reduction in IPF-related cough in a Phase 2a study